|
The consolidated financial statement of the Group includes the following list of company directly or indirectly controlled:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% equity interest |
Name |
|
Segment |
|
Description |
|
Country of incorporation |
|
Type of control |
|
2021 |
|
2020 |
Nuova Ompi S.r.l. |
|
Biopharmaceutical |
|
Production of drug containment systems and development of integrated solutions for the pharmaceutical industry |
|
Italy |
|
Direct |
|
100% |
|
100% |
Spami S.r.l. |
|
Engineering |
|
Production plant and machinery |
|
Italy |
|
Direct |
|
100% |
|
100% |
Stevanato Group International a.s. |
|
Holding |
|
Service/Subholding company |
|
Slovakia |
|
Direct |
|
100% |
|
100% |
Medical Glass a.s. |
|
Biopharmaceutical |
|
Production of drug containment systems |
|
Slovakia |
|
Indirect |
|
99.74% |
|
99.74% |
Stevanato Group N.A. S. de RL de CV |
|
Biopharmaceutical |
|
Service company |
|
Mexico |
|
Indirect |
|
100% |
|
100% |
Ompi N.A. S. de RL de CV |
|
Biopharmaceutical |
|
Production of drug containment systems |
|
Mexico |
|
Direct
Indirect |
|
30.76%
69.24% |
|
30.76%
69.24% |
Ompi of America inc. |
|
Biopharmaceutical |
|
Sale of drug containment systems and analytical services |
|
USA |
|
Indirect |
|
100% |
|
100% |
Ompi do Brasil I. e C. de
Em. Far. Ltda |
|
Biopharmaceutical |
|
Production of drug containment systems |
|
Brazil |
|
Direct
Indirect |
|
79%
21% |
|
79%
21% |
Ompi Pharm. Packing Techn. Co. Ltd |
|
Biopharmaceutical |
|
Production of drug containment systems |
|
China |
|
Indirect |
|
100% |
|
100% |
Innoscan A/S |
|
Engineering |
|
Production plant and machinery |
|
Denmark |
|
Indirect |
|
100% |
|
100% |
SVM Automatik A/S |
|
Engineering |
|
Production plant and machinery |
|
Denmark |
|
Indirect |
|
100% |
|
65% * |
Medirio SA |
|
Biopharmaceutical |
|
Research and development |
|
Switzerland |
|
Indirect |
|
100% |
|
100% |
Balda Medical Gmbh |
|
Biopharmaceutical |
|
Production of in-vitro diagnostic solutions |
|
Germany |
|
Direct |
|
100% |
|
100% |
Balda C. Brewer Inc. |
|
Biopharmaceutical |
|
Production of in-vitro diagnostic solutions |
|
USA |
|
Indirect |
|
100% |
|
100% |
Balda Precision Inc. |
|
Biopharmaceutical |
|
Production metal components |
|
USA |
|
Indirect |
|
100% |
|
100% |
Ompi of Japan Co., Ltd. |
|
Biopharmaceutical |
|
Sale of drug containment systems |
|
Japan |
|
Direct |
|
51% |
|
51% |
Swissfillon AG |
|
Biopharmaceutical |
|
Sterile filling services company |
|
Switzerland |
|
Associate |
|
0% |
|
26.94% |
* Not included in minority interests as there is a put and call option for full acquisition (the minority interests would have amounted to 35%).
|